Ronac Mamtani MD MSCE
Assistant Professor, Medicine, Perelman School of Medicine
Join to view full profile
3400 Civic Center Blvd2 WestPhiladelphia, PA 19104
Phone+1 215-615-5858
Fax+1 212-746-6692
Dr. Mamtani is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2009 - 2012
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2006 - 2009
Stony Brook University Health Sciences Center School of MedicineClass of 2006
Certifications & Licensure
PA State Medical License 2009 - 2026
NY State Medical License 2008 - 2010
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016
Publications & Presentations
PubMed
- Severe primary organ-related complications in patients with de novo metastatic cancer: implications for prophylactic local therapy.Hefei Liu, Dafna Merhav, Naia Tabakovic, Ronac Mamtani, Karishma Khullar
Clinical and Translational Radiation Oncology. 2026-09-01 - Neoadjuvant, adjuvant, and perioperative therapy comparisons in muscle-invasive bladder cancer: Clinical and methodological considerations for the interpretation of ne...Ronac Mamtani, Patrick Squires, Ali Mojebi, Braden Hale, Anjela Tzontcheva
Urologic Oncology. 2026-09-01 - Publisher Correction: Perioperative Treatment Patterns for Muscle-Invasive Bladder Cancer Patients Undergoing Radical Cystectomy in the Adjuvant Immunotherapy Era: A R...Patrick Squires, Ke Meng, Xiaohan Hu, Vladimir Turzhitsky, Yu-Han Kao
Oncology and Therapy. 2026-06-09
Journal Articles
- Cisplatin Versus Cetuximab with Definitive Concurrent Radiotherapy for Head and Neck Squamous Cell Carcinoma: An Analysis of Veterans Health Affairs DataRavi Vinnakota, Keith Sigel, Joshua M Bauml, Roger B Cohen, Nevena Damjanov, Corey J Langer, Ronac Mamtani, Charu Aggarwal, Christina Knepley, Juan Wisnivesky, Cancer
Authored Content
- A New Look at the International Duration Evaluation of Adjuvant Therapy (IDEA) Classification—Defining Novel Predictive and Prognostic Markers in Stage III Colon CancerMay 2018
- A New Look at the International Duration Evaluation of Adjuvant Therapy (IDEA) Classification—Defining Novel Predictive and Prognostic Markers in Stage III Colon CancerMay 2018
Press Mentions
Penn Medicine Takes on ‘Time Toxicity’ in Cancer TreatmentOctober 14th, 2025- When Cancer Care Meets Urgent CareOctober 14th, 2025
- Can Text Messages Bypass in-Person Immunotherapy Check-Ins?: Penn MedicineFebruary 26th, 2025
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
